A Prospective, Randomized Single-Masked Clinical Trial Comparing OCT and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care

NCT00698724 Phase 4 COMPLETED

To compare the efficacy of twice-daily topical bromfenac (Xibrom) ophthalmic solution alone versus twice-daily topical Xibrom with prednisolone acetate 1% three-times daily on visual acuity and OCT measurements.

Details

Lead sponsor	Bp Consulting, Inc
Phase	Phase 4
Status	COMPLETED
Enrolment	200
Start date	2008-06
Completion	2009-06

Conditions

• Cataracts

Interventions

• Xibrom, and Optive
• Xibrom and Pred Forte

Primary outcomes

• OCT — 2-4 months

Countries

United States